GSK And Oxford To Collaborate On Neoantigen Vaccines To Prevent Cancer

 
• By Andrew McConaghie
  
Oxford, UK
GSK is extending its existing relationship with the University of Oxford, home to world-class academic biomedical research. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from R&D

More from Business